Imatinib-induced cutaneous adverse reactions
- VernacularTitle:伊马替尼引起的皮肤不良反应
- Author:
Min YANG
1
;
Jianmin CHANG
Author Information
- Keywords: Drug toxicity; Skin; Mucous membrane; Imatinib
- From: Chinese Journal of Dermatology 2021;54(8):738-741
- CountryChina
- Language:Chinese
- Abstract: Imatinib mesylate is the first-line drug for the treatment of chronic myeloid leukemia and malignant gastrointestinal stromal tumors, and causes mucocutaneous adverse reactions at a high frequency. Based on Chinese and international literature, the authors comprehensively describe various mucocutaneous symptoms induced by imatinib mesylate, and summarize their pathogenesis and management strategies, aiming to help dermatologists improve their understanding of mucocutaneous adverse reactions to this drug, and provide timely diagnosis and treatment.
